Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01441531

Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension

Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension During Orif of Tibia Fracture Under General Anesthesia

Status
Withdrawn
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Baylor College of Medicine · Academic / Other
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to find out if taking a dose of gabapentin 600 mg by mouth (po) before surgery will help prevent the development of tourniquet pain and hypertension while the tourniquet is inflated during orif of tibia fracture.

Conditions

Interventions

TypeNameDescription
DRUGgabapentin 600 mg poGiven one hour before surgery
DRUGPlacebo pill given one hour before surgeryPlacebo pill given

Timeline

Start date
2012-01-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2011-09-27
Last updated
2015-03-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01441531. Inclusion in this directory is not an endorsement.